Screening for BRAF RET KRAS NRAS and HRAS mutations as well as RET-PTC1 and RET-PTC3 rearrangements was performed on cases of Hashimoto thyroiditis with a dominant nodule
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.